Cargando…
Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glyc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748946/ https://www.ncbi.nlm.nih.gov/pubmed/29291706 http://dx.doi.org/10.1186/s12875-017-0677-2 |
_version_ | 1783289496736890880 |
---|---|
author | Tourkmani, Ayla M. Abdelhay, Osama Alkhashan, Hesham I. Alaboud, Aboud F. Bakhit, Ahmed Elsaid, Tarek Alawad, Ahmed Alobaikan, Aljohara Alqahtani, Hala Alqahtani, Abdulaziz Mishriky, Adel bin Rsheed, Abdulaziz Alharbi, Turki J. |
author_facet | Tourkmani, Ayla M. Abdelhay, Osama Alkhashan, Hesham I. Alaboud, Aboud F. Bakhit, Ahmed Elsaid, Tarek Alawad, Ahmed Alobaikan, Aljohara Alqahtani, Hala Alqahtani, Abdulaziz Mishriky, Adel bin Rsheed, Abdulaziz Alharbi, Turki J. |
author_sort | Tourkmani, Ayla M. |
collection | PubMed |
description | BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glycemic control and cardiovascular risk factors. METHODS: In a randomized, parallel-group trial, we assigned 263 patients with poorly controlled type 2 diabetes mellitus (T2DM) to either a control group, standard care program, or a multidisciplinary care program involving a senior family physician, clinical pharmacy specialist, dietician, diabetic educator, health educator, and social worker. The participants were followed for a median of 10 months, between September 2013 and September 2014. Glycated hemoglobin (HbA1c), fasting blood glucose (FBG), lipid profiles, and blood pressure (BP) were measured. The assignment was blinded for the assessors of the study outcomes. The study registry number is. RESULTS: In the intervention group, there were statistically significant (p < 0.05) post-intervention (relative) reductions in the levels of HbA1c (−27.1%, 95% CI = −28.9%, −25.3%), FBG (−17.10%, 95% CI = −23.3%, −10.9%), total cholesterol (−9.93%, 95% CI = −12.7%, −7.9%), LDL cholesterol (−11.4%, 95% CI = −19.4%, −3.5%), systolic BP (−1.5%, 95% CI = −2.9%, −0.03%), and diastolic BP (−3.4%, 95% CI = −5.2%, −1.7%). There was a significant decrease in the number of patients with a HbA1c ≥10 (86 mmol/mol) from 167 patients at enrollment to 11 patients after intervention (p < 0.001). However, the intervention group experienced a statistically significant increase in body weight (3.7%, 95% CI = 2.9%, 4.5%). In the control group, no statistically significant changes were noticed in different outcomes with the exception of total cholesterol (−4.10%, p = 0.07). In the linear regression model, the intervention and the total number of clinic visits predicted HbA1c improvement. CONCLUSIONS: Implementation of a patient-specific integrated care program involving a multidisciplinary team approach, frequent clinic visits, and intensified insulin treatment was associated with marked improvement in glycemic control and cardiovascular risk factors of poorly controlled T2DM patients in a safe and reproducible manner. TRIAL REGISTRATION: ISRCTN Identifier: ISRCTN83437562 September 19, 2016 Retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-017-0677-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5748946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57489462018-01-05 Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study Tourkmani, Ayla M. Abdelhay, Osama Alkhashan, Hesham I. Alaboud, Aboud F. Bakhit, Ahmed Elsaid, Tarek Alawad, Ahmed Alobaikan, Aljohara Alqahtani, Hala Alqahtani, Abdulaziz Mishriky, Adel bin Rsheed, Abdulaziz Alharbi, Turki J. BMC Fam Pract Research Article BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glycemic control and cardiovascular risk factors. METHODS: In a randomized, parallel-group trial, we assigned 263 patients with poorly controlled type 2 diabetes mellitus (T2DM) to either a control group, standard care program, or a multidisciplinary care program involving a senior family physician, clinical pharmacy specialist, dietician, diabetic educator, health educator, and social worker. The participants were followed for a median of 10 months, between September 2013 and September 2014. Glycated hemoglobin (HbA1c), fasting blood glucose (FBG), lipid profiles, and blood pressure (BP) were measured. The assignment was blinded for the assessors of the study outcomes. The study registry number is. RESULTS: In the intervention group, there were statistically significant (p < 0.05) post-intervention (relative) reductions in the levels of HbA1c (−27.1%, 95% CI = −28.9%, −25.3%), FBG (−17.10%, 95% CI = −23.3%, −10.9%), total cholesterol (−9.93%, 95% CI = −12.7%, −7.9%), LDL cholesterol (−11.4%, 95% CI = −19.4%, −3.5%), systolic BP (−1.5%, 95% CI = −2.9%, −0.03%), and diastolic BP (−3.4%, 95% CI = −5.2%, −1.7%). There was a significant decrease in the number of patients with a HbA1c ≥10 (86 mmol/mol) from 167 patients at enrollment to 11 patients after intervention (p < 0.001). However, the intervention group experienced a statistically significant increase in body weight (3.7%, 95% CI = 2.9%, 4.5%). In the control group, no statistically significant changes were noticed in different outcomes with the exception of total cholesterol (−4.10%, p = 0.07). In the linear regression model, the intervention and the total number of clinic visits predicted HbA1c improvement. CONCLUSIONS: Implementation of a patient-specific integrated care program involving a multidisciplinary team approach, frequent clinic visits, and intensified insulin treatment was associated with marked improvement in glycemic control and cardiovascular risk factors of poorly controlled T2DM patients in a safe and reproducible manner. TRIAL REGISTRATION: ISRCTN Identifier: ISRCTN83437562 September 19, 2016 Retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-017-0677-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-02 /pmc/articles/PMC5748946/ /pubmed/29291706 http://dx.doi.org/10.1186/s12875-017-0677-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tourkmani, Ayla M. Abdelhay, Osama Alkhashan, Hesham I. Alaboud, Aboud F. Bakhit, Ahmed Elsaid, Tarek Alawad, Ahmed Alobaikan, Aljohara Alqahtani, Hala Alqahtani, Abdulaziz Mishriky, Adel bin Rsheed, Abdulaziz Alharbi, Turki J. Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title | Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title_full | Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title_fullStr | Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title_full_unstemmed | Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title_short | Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study |
title_sort | impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in saudi arabia: an interventional parallel-group controlled study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748946/ https://www.ncbi.nlm.nih.gov/pubmed/29291706 http://dx.doi.org/10.1186/s12875-017-0677-2 |
work_keys_str_mv | AT tourkmaniaylam impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT abdelhayosama impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alkhashanheshami impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alaboudaboudf impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT bakhitahmed impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT elsaidtarek impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alawadahmed impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alobaikanaljohara impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alqahtanihala impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alqahtaniabdulaziz impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT mishrikyadel impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT binrsheedabdulaziz impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy AT alharbiturkij impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy |